» Articles » PMID: 8346497

Effect of Seasonal Allergic Rhinitis on Airway Mucosal Absorption of Chromium-51 Labelled EDTA

Overview
Journal Thorax
Date 1993 Jun 1
PMID 8346497
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hyperpermeability of the airway mucosa is thought to be characteristic of allergic rhinitis and asthma. Nine subjects with seasonal rhinitis caused by birch pollen were studied and the nasal mucosal absorption of chromium-51 labelled EDTA was examined both in an asymptomatic period before the season and late into the season when significant allergic rhinitis symptoms were present.

Methods: A nasal pool device was used to keep a concentration of the absorption tracer in contact with a larger part of the mucosa of the ipsilateral nasal cavity. Absorption was allowed for 15 minutes and measured as the radioactivity appearing in the 24 hour urine sample.

Results: The nasal absorption of 51Cr-EDTA in subjects with seasonal allergic rhinitis was less during active disease than before the season.

Conclusions: An airway epithelial barrier that is subject to prolonged eosinophilic inflammation may not be disrupted but may rather increase its functional tightness.

Citing Articles

Well-controlled mucosal exudation of plasma proteins in airways with intact and regenerating epithelium.

Persson C Physiol Rep. 2024; 12(11):e16096.

PMID: 38837627 PMC: 11150058. DOI: 10.14814/phy2.16096.


Dehydration affects drug transport over nasal mucosa.

Ali A, Wahlgren M, Rembratt-Svensson B, Daftani A, Falkman P, Wollmer P Drug Deliv. 2019; 26(1):831-840.

PMID: 31401887 PMC: 6713119. DOI: 10.1080/10717544.2019.1650848.


Airways exudation of plasma macromolecules: Innate defense, epithelial regeneration, and asthma.

Persson C J Allergy Clin Immunol. 2018; 143(4):1271-1286.

PMID: 30170125 PMC: 7112321. DOI: 10.1016/j.jaci.2018.07.037.


The effect of terbutaline on the absorption of pulmonary administered insulin in subjects with asthma.

Petersen A, Korsatko S, Kohler G, Wutte A, Olschewski H, Sparre T Br J Clin Pharmacol. 2010; 69(3):271-8.

PMID: 20233198 PMC: 2829697. DOI: 10.1111/j.1365-2125.2009.03573.x.


Epithelial barrier formation by airway basal cells.

Erjefalt J, Sundler F, Persson C Thorax. 1997; 52(3):213-7.

PMID: 9093334 PMC: 1758525. DOI: 10.1136/thx.52.3.213.


References
1.
Buckle F, Cohen A . Nasal mucosal hyperpermeability to macromolecules in atopic rhinitis and extrinsic asthma. J Allergy Clin Immunol. 1975; 55(4):213-21. DOI: 10.1016/0091-6749(75)90139-6. View

2.
Elwood R, Kennedy S, Belzberg A, Hogg J, Pare P . Respiratory mucosal permeability in asthma. Am Rev Respir Dis. 1983; 128(3):523-7. DOI: 10.1164/arrd.1983.128.3.523. View

3.
Kovacs J, Gill V, Swan J, Ognibene F, Shelhamer J, Parrillo J . Prospective evaluation of a monoclonal antibody in diagnosis of Pneumocystis carinii pneumonia. Lancet. 1986; 2(8497):1-3. DOI: 10.1016/s0140-6736(86)92555-9. View

4.
Ilowite J, Bennett W, Sheetz M, Groth M, Nierman D . Permeability of the bronchial mucosa to 99mTc-DTPA in asthma. Am Rev Respir Dis. 1989; 139(5):1139-43. DOI: 10.1164/ajrccm/139.5.1139. View

5.
Greiff L, PIPKORN U, Alkner U, Persson C . The 'nasal pool' device applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretions. Clin Exp Allergy. 1990; 20(3):253-9. DOI: 10.1111/j.1365-2222.1990.tb02680.x. View